SKI-G-1141

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSKI-G-1141
Drug Alias Nameleucine-rich repeat kinase 2 inhibitors (Genosco)LRRK2 inhibitors (Genosco)GNS-1141SKI-G-1141
ClassificationSmall molecules
Mechanisms of ActionLeucine-rich repeat serine/threonine-protein kinase 2 inhibitors
TargetsLeucine-rich repeat serine/threonine-protein kinase 2
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenosco
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenosco
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A